Nachrichten zur GW Pharmaceuticals Plc Aktie

Why GW Pharmaceuticals Stock Rocketed 40.5% in February

The cannabis-based pharmaceutical company agreed to be acquired....…

GW PHARMACEUTICALS PLC: 10-K Report

10-K...…

GW Pharma get European nod on expanded label for Epidyolex

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

GW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEX® (cannabidiol) for use as treatment of seizures associated with Tuberous Sclerosis Complex

– If approved by the European Commission (EC), the label for EPIDYOLEX® will expand to include a third indication in…

The GW Pharma and Parallel Transactions: Where Does the Future of Cannabis go From Here?

This month, two groundbreaking deals in cannabis were announced — the acquisition of GW Pharmaceuticals by Jazz Pharmaceuticals and the…

Northern Leaf: European cannabis first mover now has a clear line of sight to a London Stock Exchange listing

The $7.2bn takeover of GW Pharma has defined what success looks like for cannabis companies on this side of the…

GW Pharmaceuticals Beats on Revenue, Bottom Line for Q4

The companys net loss was far narrower than many expected....…

Mid-Day Market Update: Gold Slides Further, GW Pharma Reports Topline Growth

Midway through trading Tuesday, the Dow traded higher by 0.14% to 31,502.73, while the NASDAQ fell 0.47% to 14,029.30 and…

GW Pharmaceuticals: Q4 Earnings Insights

Shares of GW Pharmaceuticals (NASDAQ:GWPH) fell 0.2% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share were…

GW PHARMACEUTICALS PLC: 8-K Report

8-K...…

GW Pharmaceuticals EPS misses by $0.02, beats on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of GW Pharmaceuticals plc - GWPH

NEW YORK , Feb. 12, 2021 /PRNewswire/ -- …

Jazz Pharma will GW Pharma kaufen: Iren zahlen 7,2 Milliarden Dollar für Cannabis-Firma

Ein M&A-Deal im Milliardenformat rückt den Markt für Arzneimittel auf Basis von Cannabis in den Fokus: Das Geschäft fristet in…

GF Global Cannabis Opportunity Fund: M&A Paukenschlag im Biotechsektor: GW Pharmaceuticals soll für 7,2 Mrd.$ geschluckt werden.

Die Aktie ist die größte Einzelposition im GF Global Cannabis Opportunity Fund. Das irische Pharmaunternehmen Jazz Pharmaceuticals gab am 03.02.21 bekannt,…

Jazz Pharmaceuticals: GW Pharmaceuticals Acquisition Makes Sense

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Willow Biosciences is set to benefit from Jazz Pharmaceuticals acquisition of GW Pharmaceuticals

Jazz Pharmaceuticals Plcs (NASDAQ:JAZZ) recently-announced deal to acquire cannabis-derived drug maker GW Pharmaceuticals Plc (NASDAQ:GWPH) for US$7.2 billion in cash and…

Cardiol CEO sees bright future for pharmaceutically produced cannabidiol after blockbuster Jazz-GW Pharmaceutical deal

A blockbuster deal announced earlier this week could be a sign of a bright future for cannabidiol-oriented pharmaceutical companies. On…

Cannabis ETFs Spike on Jazz-GW Pharma Deal

Jazz Pharmaceuticals (JAZZ) agreed to buy cannabinoid drug company GW Pharmaceuticals (GWPH) for $7.2 billion in cash and stock that…

Cannabis Report: Große Übernahme im Sektor - Jazz Pharma kauft GW Pharmaceuticals

Die Wahlen in den USA haben dem Cannabissektor massiven Schwung verlieren. Die Erwartungen der Marktteilnehmer sind immens, was die…

Jazz Pharmaceuticals to buy cannabis pioneer GW Pharmaceuticals for US$7.2bn

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) has agreed to acquire pioneering cannabis firm GW Pharmaceuticals plc (NASDAQ:GWPH) for US$7.2bn (£5.2bn) or US$220…

GW PHARMACEUTICALS PLC: 8-K Report

8-K...…

SHAREHOLDER ALERT: WeissLaw LLP Investigates GW Pharmaceuticals plc

NEW YORK , Feb. 3, 2021 /PRNewswire/ -- WeissLaw LLP …

Jazz Pharma raised at Piper Sandler on GW Pharma deal

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Mid-Afternoon Market Update: Dow Gains 75 Points; GW Pharmaceuticals Shares Jump On Acquisition News

Toward the end of trading Wednesday, the Dow traded up 0.25% to 30,763 while the NASDAQ rose 0.5% to 13,680.71.…

Aphria, Cannabis Stocks Soar as Jazz Pharma to Buy GW Pharma

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jazz Pharma to buy GW Pharma for $7.2 billion, adding cannabis-based drug to portfolio

Jazz Pharmaceuticals Plc said on Wednesday it had agreed to buy GW Pharmaceuticals plc in a $7.2 billion cash-and-stock deal…

How to Trade Jazz Pharmaceuticals After Its Acquisition of GW Pharma

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jazz Pharmaceuticals to Acquire Cannabis Drug Company

The deal to buy GW Pharmaceuticals creates a leader in neuroscience....…

Cannabis stocks rally anew as $7 billion GW Pharma deal spurs interest in weed and its medical benefits

Cannabis stocks rallied anew on Wednesday, spurred on by news of a $7 billion deal for the first company to…

GW Pharmaceuticals: Grund ist ein Übernahmedeal! Aktienanalyse

Kulmbach (www.aktiencheck.de) - GW Pharmaceuticals-Aktienanalyse von "Der Aktionär": Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die GW…

Jazz Pharma to buy GW Pharma for $7.2 bln, adding cannabis-based drug to portfolio

Jazz Pharmaceuticals Plc said on Wednesday it had agreed to buy GW Pharmaceuticals plc in a $7.2 billion cash-and-stock deal…

In Jazz acquisition of GW Pharma, Epidiolex is tip of cannabinoid iceberg

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Rallye bei Canopy Growth, Aphria, GW Pharma & Co – Cannabis-Index mit neuem Allzeithoch

Die Aktien der Cannabis-Unternehmen sind derzeit kaum mehr zu bremsen. Am heutigen Mittwoch geht es bei den Papieren erneut kräftig…

Jazz Pharmaceuticals to Buy GW Pharma for $6.7 Billion

The deal, combining two neuroscience drugmakers, marks a bet by Jazz on the long-term prospects for cannabis-based therapies....…

Why Aurora Cannabis, Cronos And Tilray Are Trading Higher Today

The shares of several cannabis companies are trading higher on Wednesday following the announcement of the Jazz Pharma deal for…

Jazz Pharma adds cannabis-based drug in $7.2 billion deal for GW Pharma

Jazz Pharmaceuticals Plc said on Wednesday it would buy GW Pharmaceuticals plc in a $7.2 billion cash-and-stock deal to bolster…

Why GW Pharmaceuticals Stock Is Skyrocketing Today

Investors cheered an unexpected acquisition of the cannabinoid-focused biotech....…

PAOG Highlights Its Own Cannabis Pharma Tech As GW Pharma Valued At $7.2 B

SANDUSKY, Ohio , Feb. 3, 2021 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today highlighted…

Tyme Technologies, GW Pharmaceuticals leads healthcare gainers; Vaxart, Moleculin Biotech among major losers

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Cannabis-Derived Drug Maker GW Pharma Acquired by Jazz Pharma for $7.2 Billion

Um den gesamten Artikel unter feedproxy.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Thinking about trading options or stock in GW Pharmaceuticals, Bristol-Myers Squibb, Aurora Cannabis, Alibaba, or Workday?

NEW YORK , Feb. 3, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GWPH,…